Budez CR 3 mg Controlled-Release Capsules

Budez CR 3 mg controlled-release capsules deliver budesonide, a corticosteroid formulated to act mainly within the gut rather than throughout the whole body. We stock this capsule form in packs of 30, 60, 90, and 180 capsules, so customers can choose a quantity that matches their prescribed treatment plan.

Budez CR: composition, uses, and prescription status

Composition and active ingredient

Each Budez CR capsule contains 3 mg of budesonide as its only active ingredient, presented as an oral, controlled-release capsule. Inside each capsule, the budesonide is carried on small granules coated to resist stomach acid and release the drug gradually as it passes through the small intestine and into the colon. This design lets the medicine act directly on inflamed gut tissue while budesonide that is absorbed into the bloodstream is broken down extensively by the liver on its first pass, which is why systemic corticosteroid exposure is lower than with older steroids such as prednisolone.

What Budez CR treats

Budesonide capsules of this type are established for active, mild-to-moderate Crohn's disease affecting the ileum and/or ascending colon, and for collagenous colitis, a form of microscopic colitis that causes chronic watery diarrhoea. In both conditions, the corticosteroid dampens local inflammation in the bowel lining, easing symptoms such as abdominal pain, urgency, and frequent loose stools. Budesonide is not typically used for ulcerative colitis affecting the whole colon or for general allergic conditions, since its release pattern is built around the small bowel and proximal colon.

Prescription status and how we supply it

Because Budez CR reaches the circulation only after significant first-pass metabolism, it is generally handled as a corticosteroid requiring individualised medical judgement about dose, duration, and monitoring rather than everyday, unsupervised use. A UK marketing authorisation specifically under the Budez CR name has not been confirmed, so anyone substituting between budesonide brands should check that the product they receive matches what their clinician has discussed with them. We do not require a prescription document to process an order for this listing, and our pharmacist-backed support team is available every day by email, live chat, and phone to talk through suitability, dosing, and any questions before you decide to proceed.

General dosing and warnings for Budez CR

How and when to take Budez CR

For adults with active mild-to-moderate Crohn's disease or collagenous colitis, a common regimen for controlled-release budesonide capsules is 9 mg, equivalent to three 3 mg capsules, taken once daily in the morning. An induction course often lasts for up to eight weeks, but the exact dose, duration, and any subsequent dose reduction depend on the condition, response, product instructions, and prescriber's plan. The capsules should be swallowed whole with a glass of water, usually before breakfast, and should not be opened, chewed, or crushed, since this would disrupt the coating that controls where and how quickly the drug is released. Taking the dose at a consistent time helps maintain a regular routine. People who have used corticosteroids for a prolonged period or repeated courses should not reduce the dose or stop treatment abruptly without clinical advice because adrenal function may be suppressed. Grapefruit and grapefruit juice should be avoided during treatment, as they can raise budesonide levels by interfering with its breakdown in the gut wall and liver.

What to do about a missed dose

If a dose of Budez CR is forgotten, follow the instructions in the supplied patient leaflet or those given by the prescriber. A forgotten dose may generally be taken when remembered if the next dose is not due soon; if it is nearly time for the next scheduled dose, the missed dose should be skipped and the regular schedule resumed. Two doses should not be taken together to make up for a missed one, since this increases the chance of steroid-related side effects without improving control of the underlying inflammation.

What to do in case of a suspected overdose

A single extra capsule of Budez CR is unlikely to cause a dangerous acute reaction, but repeated over-dosing or long-term excessive use can produce signs of steroid excess, including marked swelling of the face, rapid weight gain, mood changes, unusually high blood pressure, or poor blood sugar control. Anyone who has taken substantially more than directed, or who develops these signs, should contact their GP, NHS 111, or our pharmacist support line for advice, and should seek urgent medical attention or go to A&E if severe symptoms such as confusion, chest pain, or fainting occur. Long-term users should never stop Budez CR suddenly on their own, since doing so can trigger adrenal insufficiency; any change in dosing after suspected overuse should be guided by a clinician.

Precautions before using Budez CR

Allergy warnings

Budez CR should not be used by anyone with a known hypersensitivity to budesonide itself or to any excipient in the capsule shell or granule coating. A general history of unrelated allergies, such as to pollen or foods, is not in itself a reason to avoid this medicine, but anyone who has previously reacted to budesonide or to another corticosteroid capsule should mention this before starting treatment.

Health condition warnings

Extra caution and monitoring are appropriate for people with diabetes, since corticosteroids can raise blood glucose and may require adjustment of diabetes medicines. Active or recent infections, including tuberculosis, chickenpox, or shingles, should be discussed with a prescriber first, as corticosteroids can mask symptoms or allow infections to spread more easily. Liver impairment can slow the breakdown of budesonide and increase systemic exposure, so dose review is often needed. People with glaucoma, cataracts, osteoporosis, high blood pressure, or a history of peptic ulcers should also be monitored, since corticosteroids can worsen each of these. Use in pregnancy is considered only when the expected benefit for the mother's bowel disease outweighs any possible risk to the pregnancy, and this should be an individual decision made with a prescriber rather than a default choice. At usual therapeutic doses, budesonide passes into breast milk only in small amounts, and it can generally continue to be used while breastfeeding. In children aged eight years and over who weigh more than 25 kg, budesonide has an established paediatric regimen for Crohn's disease, but growth and adrenal function need careful monitoring; it is not established for younger or lighter children.

Side effects of Budez CR

Because Budez CR is designed to act mainly in the gut, its side-effect profile tends to be milder than that of older, fully systemic corticosteroids, though it is not free of steroid-related effects. Commonly reported effects include headache, nausea, indigestion, bloating, and mild sleep disturbance. Some people notice acne, mild mood changes, or a modest rise in appetite. Less commonly, longer courses can produce more classic corticosteroid effects such as rounding of the face, easy bruising, muscle weakness, or changes in blood sugar and blood pressure. Warning signs that need prompt medical attention include visual disturbance or eye pain, black or tarry stools suggesting gastrointestinal bleeding, severe abdominal pain, signs of infection such as fever with a sore throat, or symptoms of adrenal insufficiency such as profound fatigue, dizziness, and low blood pressure, particularly after a dose is reduced or stopped. Anyone who develops these more serious signs should stop relying on self-management and contact a GP or our pharmacist support line the same day, or seek emergency care if symptoms are severe.

Medicine interactions with Budez CR

Budesonide is broken down mainly by an enzyme called CYP3A4, so medicines that block this enzyme can raise budesonide levels and increase the risk of steroid side effects; these include ketoconazole and related antifungals, certain macrolide antibiotics such as clarithromycin, and some HIV protease inhibitors. Cimetidine can have a smaller, similar effect. Combining Budez CR with other corticosteroids, whether oral, inhaled, or topical, adds to the total steroid burden on the body and should be discussed with a prescriber. Non-steroidal anti-inflammatory drugs, including ibuprofen and aspirin, can increase the risk of gastrointestinal irritation or bleeding when taken alongside a corticosteroid. Anticoagulant effects can occasionally be altered, so anyone on warfarin or similar medicines should have their clotting checked more closely after starting or stopping budesonide. Live vaccines are generally avoided during immunosuppressive corticosteroid treatment because of the risk of infection and a reduced immune response. A full, current list of medicines and supplements should always be shared with a prescriber or with our pharmacist team before starting Budez CR.

After using Budez CR: storage and disposal

Storage

Budez CR capsules should be stored below 25°C, kept away from direct light and damp conditions such as bathrooms, and left in their original, tightly closed container until each dose is needed. Keeping the capsules in the packaging they were dispensed in helps preserve the coating that controls their release and keeps the expiry date visible. As with any corticosteroid, capsules should be kept well out of the sight and reach of children.

Disposal

Unused or expired Budez CR capsules should not be thrown into household rubbish or flushed away, since corticosteroids can affect waterways if disposed of carelessly. The simplest route is to take any leftover capsules to a local community pharmacy, which can accept returned medicines for safe destruction through the official take-back scheme. If a course of treatment ends earlier than expected, or a prescriber changes the plan, returning the remaining capsules this way avoids the temptation to use them without current medical advice.

Alternatives to Budez CR capsules

Other budesonide-based options exist in different formulations, including gastro-resistant granules that are placed on the tongue and swallowed with liquid rather than taken as an intact capsule, and once-daily extended-release tablets designed specifically for ulcerative colitis rather than Crohn's disease or collagenous colitis. These are not interchangeable with Budez CR simply because they share the same active ingredient, since release pattern and licensed indication differ by product. For people who need a fully systemic corticosteroid effect, or whose condition does not respond adequately to a gut-targeted steroid, oral Prednisolone tablets remain a well-established alternative, though they carry a higher likelihood of whole-body steroid side effects with longer use. In inflammatory bowel disease more broadly, aminosalicylate medicines offer a non-steroid option for certain patterns of disease, though they work differently and suit different situations than a corticosteroid capsule. Anyone wanting to compare these options further is welcome to browse our Gastrointestinal Tract range, and to talk through which form best fits their diagnosis and treatment plan with our pharmacist support team before switching between any of these medicines.